Repercussions of electrostimulation in women with breast cancer during chemotherapy

Not Applicable

• Conditions: malignant neoplasm of the breast; pharmacological treatment; nausea; vomit; Q65.020; C23.888.821.712; C23.888.821.937

• Registration Number: RBR-4ccv6f
• Lead Sponsor: universidade federal de santa maria

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2018-07-03
• Last Update Posted: 29 May 2023

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: Female
• Target Recruitment: Not specified

Inclusion Criteria

Women with indications of chemotherapy neoadjuvant or adjuvant, of high and moderate emetogenic potential; age between 35 and 75 years

Exclusion Criteria

Central nervous system metastasis;second chemotherapy treatment

Study & Design

• Study Type: Intervention
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Reduction of nausea and vomiting during chemotherapy verified through the Edmonton and MASCC Antiemesis Tool questionnaires, from a significant variation of 35% intensity and 36% in the frequency of nausea and 30% in the frequency of vomiting.<br><br>